ALEXANDRIA, Virginia – Conquer Cancer®, the ASCO Foundation, in collaboration with Pfizer Global Medical Grants, today announced grants totaling $900,000 to support studies focused on identifying disparities in delivery of care and treatment outcomes for patients of color with metastatic breast cancer (mBC).
These grants are part of the Pfizer Global Medical Grants’ program “Equitable Care of Metastatic Breast Cancer (mBC) Patients: A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color”, which aims to promote and advance scientific knowledge concerning equitable care of patients with mBC by employing data-driven frameworks to define and address inequities in the delivery of patient care and outcomes.
Application review and evaluation was led by Conquer Cancer and grant funding will be provided by Pfizer Global Medical Grants.
“The challenges faced by metastatic breast cancer patients and their loved ones should not be further complicated by inadequate access to care and resources,” said Lynn McRoy, M.D., FACS, Global Medical Breast Cancer Lead, Pfizer Oncology. “We applaud these recipients and their dedication to helping those living with metastatic breast cancer as we work together as a community to address health equity and close the gaps in breast cancer care.”
Application submissions were available to only organizations based in the U.S.
The awardees are:
Maysa Abu-Khalaf, MD
Thomas Jefferson University
The impact of social determinants of health on cancer care delivery and outcomes of metastatic breast cancer patients
Julie Bradley, MD
University of Florida
Unveiling Inequities in Palliative and Supportive Care for Metastatic Breast Cancer Patients in the State of Florida
Carolyn Brown, PhD
The University of Texas at Austin
Assessing Equity of Care Across Metastatic Breast Cancer Treatment Junctures: A Data-Driven Vulnerability Cluster Approach
Generosa Grana, MD
MD Anderson Cancer Center at Cooper
Assessment of Equitable Care for Black and Women of Color with mBC
Katherine Reeder-Hayes, MD
University of North Carolina Lineberger Comprehensive Cancer Center
Impact of Social Determinants on Treatment Access and Outcomes of Metastatic Breast Cancer Among Black Women
Shoshana Rosenberg, ScD, MPH
Weill Cornell Medicine
Identifying unmet needs and barriers to receipt of psychosocial care in men and women with metastatic breast cancer from diverse racial and ethnic backgrounds treated in an urban hospital network
As the first phase of this program, each awardee will receive research funding of $150,000 for one year. The award term runs from January 1, 2022, to December 31, 2022. Grantees are expected to share their findings with the oncology community through a future grantee meeting to be convened by Conquer Cancer in late 2022. Grant recipients also will be invited to compete for additional grant funding Pfizer anticipates providing in early 2023 to implement any of the potential solutions to the care disparities uncovered during the first phase of the program.